Comparison of Local and Systemic Inflammation During Invasive Versus Noninvasive Ventilation in Rats

The impact of noninvasive ventilation (NIV) on local and systemic inflammation is poorly characterized, particularly when compared with invasive mechanical ventilation (IMV). We sought to quantify the local and systemic inflammatory response of these 2 respiratory treatments in rats with lipopolysaccharide (LPS)-induced lung injury (LPS-injured) and healthy rats. Animals were subjected to 4 h of NIV or IMV treatments at noninjurious settings, or 4 h of control treatment in which healthy or LPS-injured animals remained spontaneously breathing under isoflurane anesthesia with no respiratory support. Cytokines were then quantified in the serum and lung tissue by multiplex enzyme-linked immunosorbent assay. Contrary to our hypothesis, there were no significant differences in cytokine levels in serum or lung when comparing the NIV- and IMV-treated groups; this was true in both LPS-injured and healthy rats. However, within the LPS-injured group, pulmonary levels of interleukin (IL)-1 alpha, IL-6, and tumor necrosis factor alpha were significantly lower in the NIV-treated group than in control but not in the IMV-treated group compared with control. We conclude that NIV, unlike IMV, could attenuate local inflammation.

Automated summary

This study compared the local and systemic inflammatory responses of noninvasive ventilation (NIV) and invasive mechanical ventilation (IMV) in rats with lung injury and healthy rats. The results showed that NIV treatment significantly reduced pulmonary inflammation levels in the LPS-injured group, while there was no significant difference in the IMV-treated group compared to control.